;wherein each of R1, R2, R3, R4, and R5, independently, is H, C1-5alkyl, C2-5alkenyl, C2-5alkynyl, aryl, heteraryl, C3-8cycloalkyl, or C3-8heterocycloalkyl; each of A1 and A2, independently, is polyethylene glycol; each of G1, G2, and G3, independently, is a bond or a linking functional group; P is a protein moiety; m is 0 or an integer of 1-10; and n is an integer of 1-10. Also disclosed are a method for preparing a protein-polymer conjugate and its use in treating hepatitis B virus or hepatitis C virus infection."/>
公开/公告号EA018111B1
专利类型
公开/公告日2013-05-30
原文格式PDF
申请/专利权人 PHARMAESSENTIA CORP.;
申请/专利号EA20100070282
发明设计人 KO-CHUNG;
申请日2008-08-15
分类号A61K47/48;
国家 EA
入库时间 2022-08-21 16:41:48